Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04174807
Other study ID # 49-RC18-0155
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date December 1, 2019
Est. completion date May 1, 2022

Study information

Verified date August 2021
Source University Hospital, Angers
Contact Magali FAUCHERE
Phone +33(0)2 41 35 63 24
Email magali.fauchere@chu-angers.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Gastroschisis is a rare congenital malformation consisting in a right para-umbilical defect of the abdominal wall leading to an evisceration of the abdominal content. About 25% of the cases are associated with intestinal malformation, leading to an increase in peri-natal morbidity and mortality. No prospective study has been able to definitely describe predictive factors for complicated gastroschisis on prenatal ultrasound examinations. The aim of the current study is to prospectively look for US prenatal features predictive of complicated gastroschisis, on a national multicentric cohort. Patients will be included during the 22 weeks of amenorrhea (WA) ultrasound examination, and pre- and postnatal clinical data will be recorded up to the 6th months of the child. Data will then be analysed and compared in the groups of simple or complicated gastroschisis, in order to define pre-natal prognostic factors, to correlate them with specific prognosis, and to might better determine specific strategies for better care of these patients.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date May 1, 2022
Est. primary completion date May 1, 2022
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: Every volunteer pregnant woman, in whom an antenatal ultrasound diagnosis of gastroschisis has been carried, before the end of 22 weeks of amenorrhea. Exclusion Criteria: Lack of informed consent or refusal of the person to participate in study

Study Design


Locations

Country Name City State
France University Hospital of Amiens Amiens
France University Hospital of Angers Angers
France University Hospital of Besançon Besançon
France University Hospital of Bordeaux Bordeaux
France University Hospital of Brest Brest
France University Hospital of Caen Caen
France University Hospital of Bicêtre Clamart
France University Hospital of Clermont-Ferrand Clermont-Ferrand
France University Hospital of Dijon Dijon
France University Hospital of Grenoble Grenoble
France University Hospital of Le Havre Le Havre
France University Hospital of Le Mans Le Mans
France University Hospital of Lens Lens
France University Hospital of Lille Lille
France University Hospital of Limoges Limoges
France University Hospital of Lyon Lyon
France University Hospital of Marseille Marseille
France University Hospital of Montpellier Montpellier
France University Hospital of Nancy Nancy
France University Hospital of Nantes Nantes
France University Hospital of Nice Nice
France University Hospital of Nîmes Nîmes
France University Hospital of Orléans Orléans
France University Hospital of Necker Paris
France University Hospital of Robert Debré Paris
France University Hospital of Trousseau Paris
France University Hospital of Poitiers Poitiers
France University Hospital of René Dubos Pontoise
France University Hospital of Reims Reims
France University Hospital of Rennes Rennes
France University Hospital of Rouen Rouen
France University Hospital of Saint-Etienne Saint-Étienne
France University Hospital of Strasbourg Strasbourg
France University Hospital of Toulouse Toulouse
France University Hospital of Tours Tours
Martinique University Hospital of Fort de France Fort de France

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Angers

Countries where clinical trial is conducted

France,  Martinique, 

References & Publications (3)

Geslin D, Clermidi P, Gatibelza ME, Boussion F, Saliou AH, Le Manac'h Dove G, Margaryan M, De Vries P, Sentilhes L, Levard G, Lardy H, Arnaud A, Leclair MD, Podevin G, Schmitt F. What prenatal ultrasound features are predictable of complex or vanishing ga — View Citation

Kassa AM, Lilja HE. Predictors of postnatal outcome in neonates with gastroschisis. J Pediatr Surg. 2011 Nov;46(11):2108-14. doi: 10.1016/j.jpedsurg.2011.07.012. — View Citation

Kuleva M, Khen-Dunlop N, Dumez Y, Ville Y, Salomon LJ. Is complex gastroschisis predictable by prenatal ultrasound? BJOG. 2012 Jan;119(1):102-9. doi: 10.1111/j.1471-0528.2011.03183.x. Epub 2011 Oct 21. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Evaluation of the collar diameter/abdominal circumference ratio as a predictive factor of complex gastroschisis. The measures of the collar diameter/abdominal circumference ratio on antenatal ultrasound examination will be evaluated as predictive factor of complex gastroschisis 2,5 years
Secondary Evaluation of antenatal ultrasound in predictive diagnosis of complex gastroschisis Identify other predictive ultrasound factors of complex gastroschisis among the different ultrasound measurements, such as gastric dilatation, maximum diameter of the intraabdominal loop, ... 2,5 years
Secondary Composite predictive criterion of complex gastroschisis Define the existence of a composite predictive criterion of complex gastroschisis that incorporates all or several predictive ultrasound factors 2,5 years
Secondary Composite predictive criterion of complex gastroschisis by MRI Perform the same measurements as for outcome 3 by MRI 2,5 years
Secondary Research risk factors in the mother Search for risk factors for complex gastroschisis from medical examination of the mother (age, tobacco, drugs, body mass index, exposure to chemicals) 2,5 years
Secondary Propose a decision algorithm for prenatal management of these patients Based on identified risk factors 2,5 years
Secondary Measure the impact of complex gastroschisis on follow-up until 6 months of children Use of different parameters (clinical assessment at 6 months, medical history) to evaluate the impact of complex gastroschisis on children at 6 months 6 months of child's life
See also
  Status Clinical Trial Phase
Completed NCT00539292 - Evaluating the Use of a Silastic Spring-Loaded Silo for Infants With Gastroschisis Phase 2
Recruiting NCT03724214 - Multi-Centre Gastroschisis Interventional Study Across Sub-Saharan Africa N/A
Recruiting NCT01469208 - Music Therapy: An Adjunct To Gastroschisis Infants' Care N/A
Terminated NCT00404690 - Bedside Silo Versus Operative Closure for Gastroschisis N/A
Recruiting NCT05704257 - Fetal Repair of Complex Gastroschisis: A Safety and Feasibility Trial N/A
Completed NCT03533439 - Regional Blood Saturation Levels in Gastroschisis
Active, not recruiting NCT03393832 - Oral Care in Infants With Gastroschisis
Completed NCT03666767 - Management and Outcomes of Congenital Anomalies in Low-, Middle- and High-Income Countries
Terminated NCT03355326 - Evaluation of Glycerin Suppositories to Improve Bowel Function in Gastroschisis Phase 4
Completed NCT03185637 - Children's Surgery in Sub-Saharan Africa N/A
Completed NCT02575846 - Clinical and Biological Outcomes of Human Milk and Formula Intake After Gastroschisis Repair N/A
Terminated NCT01094587 - Sutureless vs Sutured Gastroschisis Closure N/A
Active, not recruiting NCT00127946 - Trial of AMNIOECHANGE in Gastroschisis Affected Foetuses Phase 3
Withdrawn NCT04186039 - Functional Evaluation of the Fetal Lung by Functional Magnetic Resonance Imaging - Blood Oxygenation Level Dependent (MRI-BOLD), in Congenital Diaphragmatic and Parietal Malformations N/A
Completed NCT03960320 - Health Related Quality of Life of Patients With Abdominal Wall Defects
Terminated NCT02098915 - Metoclopramide Pilot Trial Phase 3
Completed NCT01316510 - Probiotics in Infants With Gastroschisis N/A
Completed NCT04020939 - The Role of Indocyanine Green Angiography Fluorescence on Intestinal Resections in Pediatric Surgery. N/A
Recruiting NCT06072976 - The Influence of Feeding Source on the Gut Microbiome and Time to Full Feeds in Neonates With Congenital Gastrointestinal Pathologies N/A
Recruiting NCT05293353 - Neokare Safety and Tolerability Assessment in Neonates With GI Problems